MINORITY PREDOCTORAL FELLOWSHIP PROGRAM

少数族裔博士前奖学金计划

基本信息

项目摘要

DESCRIPTION (provided by applicant): Extracellular matrix (ECM) scaffolds have been successfully used in more than 300,000 human patients in both soft and hard tissue replacement applications. ECM scaffolds promote site specific tissue remodeling and are completely and rapidly degraded during the remodelling process. However, ECM-derived scaffolds are limited by the inherent mechanical and material properties of the tissue from which they are derived. Electrospun poly(ester-urethane)urea (PEUU) scaffolds represent an alternative elastomeric material that recreates the fibrous ultrastructure of the ECM. However, PEUU scaffolds lack the bioactivity inherent in the ECM scaffolds. It is the central hypothesis of the proposed research that a hybrid scaffold composed of solubilized ECM and PEUU into electrospun material will result in a bioactive elastomeric scaffold with predictable physical properties. Three specific aims are proposed: (1) to solubilize a porcine urinary bladder ECM via enzymatic degradation; (2) to electrospin and characterize a combination of the urinary bladder ECM with PEUU; and (3) to characterize the host tissue response to both the digested ECM and the polymer-ECM scaffold after implantation in an in vivo model.
描述(申请人提供):细胞外基质(ECM)支架已成功应用于30多万名人类患者的软组织和硬组织置换应用中。ECM支架促进特定部位的组织重建,并在重建过程中完全和快速地降解。然而,ECM衍生的支架受到其来源组织固有的机械和材料特性的限制。电纺聚(酯-氨酯)尿素(PEUU)支架是一种替代弹性材料,可以重建ECM的纤维超微结构。然而,PEUU支架缺乏ECM支架固有的生物活性。这项研究的中心假设是,由溶解的ECM和PEUU组成的电纺材料组成的杂化支架将产生具有可预测物理性能的生物活性弹性支架。提出了三个具体的目标:(1)通过酶降解来溶解猪膀胱ECM;(2)电旋转并表征膀胱ECM与PEUU的结合;(3)在体内模型中表征消化的ECM和聚合物-ECM支架植入后的宿主组织反应。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Donald O Freytes其他文献

Donald O Freytes的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Donald O Freytes', 18)}}的其他基金

Augmenting Vocal Fold Repair Using an Optimized Lamina Propria Extracellular Matrix Derived Hydrogel
使用优化的固有层细胞外基质衍生水凝胶增强声带修复
  • 批准号:
    10394883
  • 财政年份:
    2019
  • 资助金额:
    $ 4.35万
  • 项目类别:
Augmenting Vocal Fold Repair Using an Optimized Lamina Propria Extracellular Matrix Derived Hydrogel
使用优化的固有层细胞外基质衍生水凝胶增强声带修复
  • 批准号:
    9926119
  • 财政年份:
    2019
  • 资助金额:
    $ 4.35万
  • 项目类别:
Augmenting Vocal Fold Repair Using an Optimized Lamina Propria Extracellular Matrix Derived Hydrogel
使用优化的固有层细胞外基质衍生水凝胶增强声带修复
  • 批准号:
    10614946
  • 财政年份:
    2019
  • 资助金额:
    $ 4.35万
  • 项目类别:
Optimal Tissue Engineering Approach for Treating Injured Vocal Folds
治疗受损声带的最佳组织工程方法
  • 批准号:
    10304920
  • 财政年份:
    2018
  • 资助金额:
    $ 4.35万
  • 项目类别:
Optimal Tissue Engineering Approach for Treating Injured Vocal Folds
治疗受损声带的最佳组织工程方法
  • 批准号:
    10058832
  • 财政年份:
    2018
  • 资助金额:
    $ 4.35万
  • 项目类别:
Optimal Tissue Engineering Approach for Treating Injured Vocal Folds
治疗受损声带的最佳组织工程方法
  • 批准号:
    10530598
  • 财政年份:
    2018
  • 资助金额:
    $ 4.35万
  • 项目类别:
MINORITY PREDOCTORAL FELLOWSHIP PROGRAM
少数族裔博士前奖学金计划
  • 批准号:
    7257064
  • 财政年份:
    2006
  • 资助金额:
    $ 4.35万
  • 项目类别:

相似海外基金

A Neuropeptidergic Neural Network Integrates Taste with Internal State to Modulate Feeding
神经肽能神经网络将味觉与内部状态相结合来调节进食
  • 批准号:
    10734258
  • 财政年份:
    2023
  • 资助金额:
    $ 4.35万
  • 项目类别:
Tau protein proteolysis signaling in Alzheimer's disease
阿尔茨海默病中的 Tau 蛋白水解信号
  • 批准号:
    10728202
  • 财政年份:
    2023
  • 资助金额:
    $ 4.35万
  • 项目类别:
The Role of EpCAM Glycosylation in Breast Cancer Metastasis
EpCAM 糖基化在乳腺癌转移中的作用
  • 批准号:
    10605857
  • 财政年份:
    2023
  • 资助金额:
    $ 4.35万
  • 项目类别:
The 11S-associated immunoproteasome in mitochondrial function and metabolic disorders
线粒体功能和代谢紊乱中的 11S 相关免疫蛋白酶体
  • 批准号:
    10681643
  • 财政年份:
    2023
  • 资助金额:
    $ 4.35万
  • 项目类别:
Study of the Development and Function of the Uterine Lymphatics
子宫淋巴管发育和功能的研究
  • 批准号:
    10752545
  • 财政年份:
    2023
  • 资助金额:
    $ 4.35万
  • 项目类别:
Investigating the role of telomere failure on intestinal stem cell niche function
研究端粒衰竭对肠道干细胞生态位功能的作用
  • 批准号:
    10678095
  • 财政年份:
    2023
  • 资助金额:
    $ 4.35万
  • 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
  • 批准号:
    10649275
  • 财政年份:
    2023
  • 资助金额:
    $ 4.35万
  • 项目类别:
Developing a new aspiration catheter solution for the treatment of large and medium vessel occlusions
开发用于治疗大中型血管闭塞的新型抽吸导管解决方案
  • 批准号:
    10699636
  • 财政年份:
    2023
  • 资助金额:
    $ 4.35万
  • 项目类别:
Quantifying proteins in plasma do democratize personalized medicine for patients with type 1 diabetes
量化血浆中的蛋白质确实使 1 型糖尿病患者的个性化医疗民主化
  • 批准号:
    10730284
  • 财政年份:
    2023
  • 资助金额:
    $ 4.35万
  • 项目类别:
Airway Prevotella enhance innate immune-mediated protection against lung infection
气道普雷沃氏菌增强先天免疫介导的肺部感染保护
  • 批准号:
    10561450
  • 财政年份:
    2023
  • 资助金额:
    $ 4.35万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了